NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz

Phase 2

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 25

Registration Number: NCT00001758

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients

Phase 2

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 73

Registration Number: NCT00001282

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Etanercept to Treat Wegener's Granulomatosis

Phase 2

Completed

Conditions: Vasculitis
Wegener's Granulomatosis

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00001901

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis

Completed

Conditions: Inflammation
Vasculitis
Wegener's Granulomatosis

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 25

Registration Number: NCT00001541

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

Phase 1

Completed

Conditions: Vasculitis
Wegener's Granulomatosis

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 50

Registration Number: NCT00001764

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Mechanisms of Allergen Immunotherapy

Completed

Conditions: Asthma
Hypersensitivity

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 50

Registration Number: NCT00001910

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Treatment of Wegener's Granulomatosis With Cyclophosphamide

Phase 2

Completed

Conditions: Vasculitis
Wegener's Granulomatosis

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 200

Registration Number: NCT00001155

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Phase 2

Completed

Conditions: Acquired Immunodeficiency Syndrome
HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 85

Registration Number: NCT00001475

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts

Completed

Conditions: CD4 Lymphocytopenia
Idiopathic CD4 Positive T Lymphocytopenia

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 100

Registration Number: NCT00001319

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Effects of HIV on the Development and Function of Bone Marrow Cells

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 300

Registration Number: NCT00001243

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy